Slide 1: Braskem
Braskem_ YY
Slide 2: Quarter highlights, operations and ESG
Higher than in 3023 Ensuring coverage of debt maturities over i {+8523 millon) and Us$211 million Pee US$3.6 billion the next 72 months Around R$1,049 million million) ot oo Utilization rate of ance petal result of fixed cost 84% feedstock supply reduction initiatives, +18 p.p.vs. 3023 administrativ
Slide 3: Average utilization rate of petrochemical crackers
Average utilization rate of petrochemical crackers: reduction in relation to 3Q23 (-2 p.p.) and 4Q22 (-6 p.p.) is explained by: (i) the scheduled maintenance shutdown in the petrochemical complex in Bahia, which lasted around 50 days; (ii) lower feedstock availability at the São Paulo petrochemical
Slide 4: Resin sales volume in the Brazilian market
c) Resin sales volume: in the Brazilian market, resin sales were lower in relation to 3Q23 (-11%), mainly explained by: (i) the prioritization of sales with higher added value; and (ii) the seasonality of the period. In relation to 4Q22, resin sales volume in the Brazilian market decreased (-9%) due
Slide 5: Resin exports
The resin exports in 4Q23 were higher when compared to 3Q23 (+2%) and 4Q22 (+8%), mainly due to the PE and PP commercial opportunities in South America.
Slide 6: Sales volume of main chemicals
d) Sales volume of main chemicals 1 : in the Brazilian market, main chemicals sales were higher than in 3Q23 (+2%) due to normalization in the production of some customers who conducted their scheduled shutdowns over the last few months. In relation to 4Q22, the reduction (-15%) is mainly explained
Slide 7: Main chemicals exports
The exports decreased (-9%) compared to 3Q23 due to the lower availability of products for sale caused by the scheduled maintenance shutdown in the petrochemical complex in Bahia. In relation to 4Q22, the increase (+10%) is explained by higher gasoline sales volume in the international market due to
Slide 8: Updates about Alagoas provisions
Provisions (R$ million) 2023 2022 4.1.2 UPDATES ABOUT ALAGOAS The Management of Braskem, based on its assessment and that of its external advisers, considering the short- and long-term effects shown in technical studies, and the best estimate of expenses for implementing diverse measures connected w
Slide 9: Sales by economic activity: PE, PP, PVC Brazil
‘Soles by Economic tivity PE | Baa Seles by Economic Activity P | Bras Sales by Economic Activity PVC | Brazil | | i son 25 co sa 303 “08 oo 103 Morte Mi consnction Ml Autonetive Mi commetic Pharmaceutial Mi Consumer goods Ml Tente sector Mi Reta usiness Hl taste i Aarcsturl sector
Slide 10: Cost of Goods Sold
B) Cost of Goods Sold (COGS): decreased in U.S. dollar (-2%) and remained in line in Brazilian real compared to 3Q23, mainly explained by: (i) the reduction of 98 kton, or 11%, in resin sales volume in the Brazilian market and of 8 kton, or 9%, in sales volume of the main chemicals in the internatio
Slide 11: SG&A expenses, Recurring EBITDA and Renewables utilization
C) SG&A EXPENSES: in U.S. dollar, the increase in relation to 3Q23 (+16%) and 4Q22 (+17%) are mainly explained by higher provisions for losses on accounts receivable, which was partially offset by efforts to reduce fixed costs carried out in the period. With respect to 4Q22, SG&A remained in line as
Slide 12: Green PE sales volume
b) Sales volume Green PE (I’m green TM biobased): increase compared to 3Q23 (+17%) mainly explained by: (i) the higher availability of product for sale due to the green PE inventory replenishment process, after the conclusion of the bio ethylene production capacity expansion project; and (ii) the in
Slide 13: Sales of green PE by quarter and region
‘Sales (kton) of green PE| Quarterly ‘Sales (kton) of green PE| Annual 3023 2023 Green PE I Crean PE ‘Green PE Sales Volume per Region (%) | Quarter (Green We Eales Volume per Region 096) | Ansel azz 3023 023 Wi cxropo BL Brat (South Amores Wl cwrope Lor (i south Amores Ate Bi north america Ata Bi N
Slide 14: United States & Europe
4.2 UNITED STATES & EUROPE Recurring EBITDA was US$87 million (R$430 million), 45% higher than in 3Q23 and 479% higher than 4Q22, and accounting for 37% of the Company’s consolidated Recurring EBITDA in 4Q23. The increase is mainly explained by the sales mix optimization and flexibility in purchase
Slide 15: Average utilization rate of PP plants
b) Average utilization rate of PP plants: remained in line with 3Q23. Increased (+7 p.p.) when compared to 4Q22 mainly explained by: (i) lower utilization rate in 4Q22 due to the adjustments of production volume to inventory levels and demand in the United States converters chain; and (ii) PP invent
Slide 16: PP sales volume
c) PP sales volume: lower when compared to 3Q23 (-6%) due to lower demand in the regions, mainly explained by: (i) the seasonality of the period; and (ii) the destocking process in the converter chain in the United States, representing, however, a smaller reduction compared to the variation in deman
Slide 17: US & Europe sales volume
‘Sales Volume (kton) | Quarterly | US & Europe Sales Volume (kton) | Annual | US & Europe 1%
Slide 18: COGS 4Q23 and 2023 United States and Europe
‘COGS 4923 | United States and Europe* ‘COGS 2023 | United States and Europe 422 3023 4023 72022 2023 i rropyiene us Mi riced cont? ElectricEneroy Proprsne EU Sales Fright Ml Natural 2= [Wh Other Variable Costs? Il Deprec/Amort ‘conlderaceunting tures “sucar fos, harness tere
Slide 19: Average utilization rate of PE plants, Mexico
b) Average utilization rate of PE plants: increased in relation to 3Q23 (+18 p.p.) mainly due to the production resumption after the unscheduled shutdown in 3Q23. In relation to 4Q22, the increase (+15 p.p.) is explained by the production normalization due to the higher availability of feedstock. In
Slide 20: PE sales volume
c) PE sales volume decreased compared to 3Q23 (-17%) and remained in line with 4Q22, mainly due to inventory rebuilding and the seasonality of the period.
Slide 21: Mexico financial overview
MEXICO 4Q23 3Q23 4Q22 Chg. Chg. 2023 2022 Chg. (A) (B) (C) (A)/(B) (A)/(C) (D) (E) (D)/(E) Net Revenue 199 217 205 -8% -3% 890 1,134 -21% Gross Profit 8 -16 -49 n.a. n.a. 16 151 -89% SG&A (49) (36) (23) 34% 115% (124) (88) 42% Net Revenue 987 1,056 1,075 -7% -8% 4,449 5,834 -24% Gross Profit 42 -81
Slide 22: Sales by economic activity: Mexico
Sales by Economic Activity | Quarterly | Mexico Sales by Economic Actiity| Annual | Mexico 11% 3923, 4923 Wi sxcsa rims MM Hysiencand Clesning ML Industat Chemis ackaging Ml Construction &Infrastructore
Slide 23: Cost of Goods Sold, Mexico
B) Cost of Goods Sold (COGS): compared to 3Q23, the decline in both U.S. dollar (-18%) and Brazilian real (-17%) is mainly due to (i) the 23% drop in ethane prices in the international market, considering its average price of each quarter; and (ii) reduction of 36 kton, or 17%, in PE sales volume in
Slide 24: Investments, SG&A and Recurring EBITDA, Mexico
Investments R$ MM US$ MM 2023 2023e Chg. 2023 2023e Chg. Mexico Operating 233 348 -33.0% 47 63 -26% Strategic¹ 240 270 -11.2% 48 49 -2% Total 473 618 -23% 95 112 -15% C) SG&A EXPENSES: the increase in relation to 3Q23 and 4Q22 in U.S. dollar and Brazilian real, is explained, mainly, by expenses rela
Slide 25: Corporate credit rating - Braskem Idesa
Agency Rating Outlook Date FITCH B+ Negative 12/20/2023 S&P B Negative 07/07/2023 Ratings CORPORATE CREDIT RATING - BRASKEM IDESA
Slide 26: Net revenue, quarterly and annual, consolidated
‘Net Revenue (R$ million) | Quarterly | Consolidated" 55% 4922 3023 4923 Mi brazil Ml Green PE + ETRE ll Mexico Ml Exports: Hl USA and Europe Da ot ara dito ead tare ‘Net Revenue (R$ million) | Annual | Consolidated! 2022, 203 Wi brazil Ml Green PE + ETBE fl Mexico Bi Exports? USA and Europe
Slide 27: Other revenue (expense), net
OTHER REVENUE (EXPENSE), NET¹ 4Q23 3Q23 4Q22 Chg. Chg. 2023 2022 Chg. R$ million (A) (B) (C) (A)/(B) (A)/(C) (D) (E) (D)/(E) Total Other Revenues 436 188 297 132% 47% 1,769 507 n.a% Total Other Expenses (1,170) (190) (599) n.a. 95% (2,735) (2,344) 17% OTHER REVENUE (EXPENSE), NET (734) (2) (302) n.a
Slide 28: Consolidated financial result
Financial Result (R$ million) 4Q23 3Q23 4Q22 Chg. Chg. 2023 2022 Chg. Consolidated (A) (B) (C) (A)/(B) (A)/(C) (D) (E) (D)/(E) Financial Expenses (1,592) (1,413) (1,489) 13% 7% (5,588) (5,066) 10% Others (621) (472) (658) 32% -6% (1,808) (1,941) -7% 495 432 438 14% 13% 1,678 1,374 22% Others (27) 80
Slide 29: Debt profile
Debt Profile (US$ million) 12/31/2023 °° mc 33% 10% 10% 7% i ba 42/31/2023 2024 2025 2029 2030 2031 20322033 onwards Cash Total cash I Total debt Sustainability linked loan? Ml Standby * Does nat conse the amount of USS35 milion destined o the Financial Compensation and Relocation Support Program in
Slide 30: Corporate credit ratings and capital markets
Agency Rating Outlook Date FITCH BB+ Rating Watch Negative 12/14/2023 S&P BB+ Stable 02/26/2024 Agency Rating Outlook Date FITCH AAA(bra) Rating Watch Negative 14/12/2023 S&P brAAA Stable 02/26/2024 Ratings CORPORATE CREDIT RATING - GLOBAL SCALE CORPORATE CREDIT RATING - NATIONAL SCALE 6. CAPITAL MA
Slide 31: Stock performance
Stock Performance 160 120 F "Dec Jan Feb Mar ‘Apr May Jun Jul Aug Sep Oct Nov Dec —IEOY — BRKMS — BRKNS — BAK Source: Blomberg
Slide 32: Performance of corporate debt securities
6.2 PERFORMANCE OF CORPORATE DEBT SECURITIES
Slide 33: Corporate debt securities performance
Vai Var. Var. @)-@) _()-(_(&)-(0) raskem ‘28 44750 Janj28 450% «10.13% 7.73% «6.98% 323% «32% 2% JBraskem "30 1,500.0 Jan/30 450% 9.49% 830% 7.25% «= 3.80% 3.80% 2.75% Jerackem "31 850.0 Jany3t 8.50% 9.97% 8.65% WA 0.15% © 0.15% NIA JBrackem ‘33, 1,000.0 Fev/33 725% 10.05% 8.48% NA 123% = 1.23% «© N
Slide 34: Consolidated recurring EBITDA calculation
7.4 CONSOLIDATED RECURRING EBITDA CALCULATION
Slide 35: Recurring EBITDA by segment
7.5 RECURRING EBITDA BY SEGMENT
Slide 36: Consolidated recurring EBITDA tables
Monch Omri lon) CONSOLIDATID Wathen COGS GumPomt otk CO Reema OTN Ne a 70 Ae) SOR) on eM) a9 US on ope wm om) a = oe ” = wes se oo, 2 ow : Bt @ i Segue Yaad ies Gs.) aaee 67 = a) is Cie See ie oo © 2 o : ie ue Conse : cc : wD om Elmiations ad ection? on as ae 2 = om 22 ss) frase Toul 7ee1 Gsm) aoe G
Slide 37: Valuation and financial indicators
Brackam Ider (7506) 125 Ea 158 7% Ev/Recurring EBITDALTM, ise Bz Sax 3306 76% FCF Vield (96) 25% 2 18% pp. pp. TSR (9%) 10% 239% 6% 39pp 6 pp. {TE considers the Recuring EBITDA in ration to net revenue 2Does not consider Net Debt, Recuing EBITDA and Interest Paid of Braskem Idesa “For leverage purpo
Slide 38: Consolidated balance sheet
ASSETS (R§ milion) Current Dec/23 13} 37,441 Dec/22 (8) 34,457 Change (y/o) ‘Cash and Cash Equivalents Marketable Securties/Held for Trading Accounts Receivable Inventories Recoverable Taxes Prepaid expenses Derivatives ‘Other Assets 14,187 4,956 2,910 12,532 1461 228 137 330 12,466 2,295 3,232 14,0
Slide 39: Cash flow statement
4923, -3Q23- 4Q22— Change Change 2022 Change (a) () (SROVOMONG) © _ (Ke) Profit (Loss) Before Income Tax and Social Contribution (2,827) (3,030) (2,227) -40% -18% (6192) 47a. “Adjust for Result Restatement ‘Depreciation and Amortization 1386 «12850441 8% 3% 5206 4,733 10% Equity Result 1 3 ©) 74% na
Slide 40: Braskem Idesa balance sheet
7.10 BRASKEM IDESA BALANCE SHEET
Slide 41: Braskem Idesa assets and liabilities
ASSETS (R$ million) Dec/23 Dec/22 Change (A) (B) (A)/(B) Current 3,525 3,685 4% ‘Cash and Cash Equivalents 1,562 2,184 28% ‘Accounts Receivable 120 73 64% Inventories 1,055 1,108 5% Recoverable Taxes 537 251 114% Derivatives e - Other 246 69 Non Current 16,477 16,108 Taxes Recoverable 225 7289 Defer
Slide 42: Forward-looking statements
This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumst